The Food and Drug Administration (FDA) on Wednesday issued a revision to its emergency use authorization (EUA) for Pfizer's COVID-19 antiviral Paxlovid that allows pharmacist to prescribe the treatment with certain limitations. Under the original EUA from the FDA, only physicians, advanced practice registered nurses and physician assistants were permitted to prescribe Paxlovid to patients. The FDA said in its announcement that state-licensed pharmacists would now be able to prescribe Paxlovid, meaning many more pharmacy locations will now be able to provide coronavirus antivirals to patient sooner. According to the FDA's revised authorization, people who have tested positive for COVID
Hence then, the article about fda issues limited authorizations for pharmacists to prescribe paxlovid was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA issues limited authorizations for pharmacists to prescribe Paxlovid )